Literature DB >> 10233711

Characterization of immune responses following intramuscular DNA immunization with the MOMP gene of Chlamydia trachomatis mouse pneumonitis strain.

D J Zhang1, X Yang, C Shen, R C Brunham.   

Abstract

Studies were carried out to characterize the cellular and humoral immune responses evoked by intramuscular DNA vaccination with the major outer membrane protein (MOMP) gene of Chlamydia trachomatis mouse pneumonitis strain. The data demonstrate that DNA vaccinated mice develop antigen-specific delayed-type hypersensitivity, lymphocyte proliferation and interferon-gamma (IFN-gamma) production. Serum antibody responses (mainly immunoglobulin G2a; IgG2a) were evoked in two-thirds of the mice. We conclude that intramuscular DNA immunization with the MOMP gene evokes cellular and humoral immune responses suggestive of a T helper 1 (Th1) bias.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10233711      PMCID： PMC2326737          DOI： 10.1046/j.1365-2567.1999.00682.x

Source DB:  PubMed          Journal:  Immunology        ISSN： 0019-2805            Impact factor:   7.397


  35 in total

Review 1.  Challenge of Chlamydia research.

Authors:  R S Stephens
Journal:  Infect Agents Dis       Date:  1992-12

2.  Heterotypic protection of mice against chlamydial salpingitis and colonization of the lower genital tract with a human serovar F isolate of Chlamydia trachomatis by prior immunization with recombinant serovar L1 major outer-membrane protein.

Authors:  M Tuffrey; F Alexander; W Conlan; C Woods; M Ward
Journal:  J Gen Microbiol       Date:  1992-08

3.  Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes.

Authors:  T M Fu; J B Ulmer; M J Caulfield; R R Deck; A Friedman; S Wang; X Liu; J J Donnelly; M A Liu
Journal:  Mol Med       Date:  1997-06       Impact factor: 6.354

4.  Experimental inclusion conjunctivitis in man: measurements of infectivity and resistance.

Authors:  E Jawetz; L Rose; L Hanna; P Thygeson
Journal:  JAMA       Date:  1965-11-08       Impact factor: 56.272

5.  Field trial of a monovalent and of a bivalent mineral oil adjuvant trachoma vaccine in Taiwan school children.

Authors:  R L Woolridge; J T Grayston; I H Chang; K H Cheng; C Y Yang; C Neave
Journal:  Am J Ophthalmol       Date:  1967-05       Impact factor: 5.258

6.  Immunostimulatory DNA sequences necessary for effective intradermal gene immunization.

Authors:  Y Sato; M Roman; H Tighe; D Lee; M Corr; M D Nguyen; G J Silverman; M Lotz; D A Carson; E Raz
Journal:  Science       Date:  1996-07-19       Impact factor: 47.728

7.  Genetically determined differences in IL-10 and IFN-gamma responses correlate with clearance of Chlamydia trachomatis mouse pneumonitis infection.

Authors:  X Yang; K T HayGlass; R C Brunham
Journal:  J Immunol       Date:  1996-06-01       Impact factor: 5.422

8.  A poliovirus hybrid expressing a neutralization epitope from the major outer membrane protein of Chlamydia trachomatis is highly immunogenic.

Authors:  A D Murdin; H Su; D S Manning; M H Klein; M J Parnell; H D Caldwell
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

9.  The epidemiology of Chlamydia trachomatis within a sexually transmitted diseases core group.

Authors:  R C Brunham; J Kimani; J Bwayo; G Maitha; I Maclean; C Yang; C Shen; S Roman; N J Nagelkerke; M Cheang; F A Plummer
Journal:  J Infect Dis       Date:  1996-04       Impact factor: 5.226

10.  Poliovirus hybrids expressing neutralization epitopes from variable domains I and IV of the major outer membrane protein of Chlamydia trachomatis elicit broadly cross-reactive C. trachomatis-neutralizing antibodies.

Authors:  A D Murdin; H Su; M H Klein; H D Caldwell
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441
View more
  7 in total

Review 1.  Immunity to murine chlamydial genital infection.

Authors:  Richard P Morrison; Harlan D Caldwell
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

2.  Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production.

Authors:  Ashlesh K Murthy; James P Chambers; Patricia A Meier; Guangming Zhong; Bernard P Arulanandam
Journal:  Infect Immun       Date:  2006-11-21       Impact factor: 3.441

3.  Immunization with Chlamydia psittaci plasmid-encoded protein CPSIT_p7 induces partial protective immunity against chlamydia lung infection in mice.

Authors:  Yuan Tan; Yumeng Li; Yang Zhang; Jian Yu; Yating Wen; Chuan Wang; Man Xu; Qian Chen; Chunxue Lu; Yimou Wu
Journal:  Immunol Res       Date:  2018-08       Impact factor: 2.829

4.  Priming with Chlamydia trachomatis major outer membrane protein (MOMP) DNA followed by MOMP ISCOM boosting enhances protection and is associated with increased immunoglobulin A and Th1 cellular immune responses.

Authors:  Z Dong-Ji; X Yang; C Shen; H Lu; A Murdin; R C Brunham
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

5.  Adjuvant modulation of the immune responses and the outcome of infection with Chlamydia pneumoniae.

Authors:  L Bandholtz; M R Kreuger; C Svanholm; H Wigzell; M E Rottenberg
Journal:  Clin Exp Immunol       Date:  2002-12       Impact factor: 4.330

6.  Chlamydia trachomatis native major outer membrane protein induces partial protection in nonhuman primates: implication for a trachoma transmission-blocking vaccine.

Authors:  Laszlo Kari; William M Whitmire; Deborah D Crane; Nathalie Reveneau; John H Carlson; Morgan M Goheen; Ellena M Peterson; Sukumar Pal; Luis M de la Maza; Harlan D Caldwell
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

Review 7.  Insights Into Host Cell Cytokines in Chlamydia Infection.

Authors:  Wenjing Xiang; Nanyan Yu; Aihua Lei; Xiaofang Li; Shui Tan; Lijun Huang; Zhou Zhou
Journal:  Front Immunol       Date:  2021-05-21       Impact factor: 7.561
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.